Zdon, Jon http://orcid.org/0009-0007-4273-8395
Chatgilaou, Greta-James
Henderson, David
Britland, Matthew
Tregenza, Sarah
McNeil, Nathalie
Otto, Dirk
Downey, Josie
Article History
Accepted: 22 May 2024
First Online: 13 July 2024
Declarations
:
: No funding was received for the publication of this article. Open Access was funded by the first author<b>.</b>
: Jon Zdon is a director of an independent Medical Affairs Consulting company (Third Pillar Consulting). Greta James is a director of an independent Medical Affairs Consulting company. David Henderson is the Managing Director of Biogen (Australia & New Zealand). Matthew Britland is a director of an independent Medical Affairs Consulting company (MedWise Consulting). Dr Sarah Tregenza is a Regional Medical Affairs Director for Pierre Fabre. Nathalie McNeil is a Vice President and General Manager for AbbVie (Australia & New Zealand). Dirk Otto is a General Manager for Boehringer Ingelheim (Australia & New Zealand). Josie Downey is a Managing Director of Merck Healthcare (Australia & New Zealand). The opinions expressed in this article are those of the authors and not necessarily those of the companies that they are employed by.
: Survey data are provided as Supplementary Information.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Jon Zdon: idea for article, data collection, data interpretation, drafted manuscript, collated comments, revised manuscript. Greta-James Chatgilaou: idea for article, data collection, data interpretation, revised manuscript. David Henderson: idea for article, data collection, data interpretation, revised manuscript. Matthew Britland: idea for article, provided comments and copyediting. Sarah Tregenza: provided extensive comments, copyediting, revised manuscript. Nathalie McNeil: provided extensive comments, copyediting, revised manuscript. Dirk Otto: provided comments, copyediting, revised manuscript. Josie Downey: provided comments, copyediting, revised manuscript. All authors have reviewed the paper and then discussed it within the author team to arrive at a final version. All authors have read and approved the final version of the submitted paper.